Tourmaline Bio, Inc. - Common Stock (NQ:TRML)
All News about Tourmaline Bio, Inc. - Common Stock
 
    
    
   From Avalo Therapeutics
   Via GlobeNewswire
    
    
    
    
    
    
    
    
    
    
   
    Tourmaline Bio Announces Pricing of Public Offering of Common Stock
    
   January 25, 2024
   From Tourmaline Bio, Inc.
   Via GlobeNewswire
    
    
   
    Tourmaline Bio Announces Proposed Public Offering of Common Stock
    
   January 24, 2024
   From Tourmaline Bio, Inc.
   Via GlobeNewswire
    
   From Tourmaline Bio, Inc.
   Via GlobeNewswire
    
    
    
    
    
   
    Tourmaline Bio added to the NASDAQ Biotechnology Index
    
   December 15, 2023
   From Tourmaline Bio, Inc.
   Via GlobeNewswire
    
   
    Tourmaline Bio Appoints Dr. Clay Siegall as Chairman of the Board
    
   December 14, 2023
   From Tourmaline Bio, Inc.
   Via GlobeNewswire
    
    
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
